Literature DB >> 7808046

Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations.

P A Pellikka1, V L Roger, J K Oh, F A Miller, J B Seward, A J Tajik.   

Abstract

OBJECTIVE: To describe the rationale, methods, and clinical applications for dobutamine stress echocardiography.
DESIGN: We review our experience with the first 1,000 Mayo Clinic patients who underwent this procedure and discuss studies from the literature that have assessed the accuracy of dobutamine stress echocardiography in determining the presence and extent of coronary artery disease.
MATERIAL AND METHODS: The Mayo protocol for dobutamine stress echocardiography is presented, and the indications for use of this test and comparisons of sensitivity and specificity with other tests are summarized.
RESULTS: Although exercise stress testing is the usual noninvasive method for the detection and assessment of coronary artery disease, a substantial number of patients are unable to perform adequate exercise because of physical limitations. In these patients, dobutamine stress echocardiography has emerged as a feasible, safe, and accurate method for the evaluation of coronary artery disease. The test has been proved to be valuable in the noninvasive diagnosis of coronary artery disease and to have an accuracy comparable to that of tomographic perfusion imaging. Other indications for dobutamine stress echocardiography include risk stratification before noncardiac surgical procedures, risk stratification after myocardial infarction, and identification of viable myocardium in patients with left ventricular dysfunction.
CONCLUSION: Dobutamine stress echocardiography is an accurate, safe, cost-effective, and portable procedure for the noninvasive diagnosis of coronary artery disease and for the preoperative assessment of patients with such disease, especially those who are unable to perform adequate exercise tests.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7808046     DOI: 10.1016/S0025-6196(11)64660-0

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  16 in total

1.  Post-myocardial infarction risk stratification with stress nuclear myocardial perfusion imaging versus echocardiography: separate but not equal.

Authors:  K A Brown
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

Review 2.  Stress echocardiography in the diagnosis of coronary artery disease.

Authors:  W Mazur; S F Nagueh
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

3.  Contrast echocardiography for left ventricular opacification.

Authors:  J Timperley; A R J Mitchell; H Becher
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

4.  Tolerance, hemodynamic changes, and safety of dobutamine stress perfusion imaging.

Authors:  H A Dakik; H Vempathy; M S Verani
Journal:  J Nucl Cardiol       Date:  1996 Sep-Oct       Impact factor: 5.952

Review 5.  Stress echocardiography for the detection and assessment of coronary artery disease.

Authors:  Nowell M Fine; Patricia A Pellikka
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

Review 6.  Challenging cardiac function post-spinal cord injury with dobutamine.

Authors:  Kathryn M DeVeau; Emily K Martin; Nicholas T King; Alice Shum-Siu; Bradley B Keller; Christopher R West; David S K Magnuson
Journal:  Auton Neurosci       Date:  2016-12-23       Impact factor: 3.145

7.  Differing autonomic responses to dobutamine stress in the presence and absence of myocardial ischaemia.

Authors:  Rajan Sharma; Jamie M O'Driscoll; Ansuman Saha; Mukunthan Sritharan; Richard Sutton; Stuart D Rosen
Journal:  J Physiol       Date:  2015-03-19       Impact factor: 5.182

Review 8.  Dobutamine stress echocardiography: safety in diagnosing coronary artery disease.

Authors:  F Lattanzi; E Picano; E Adamo; A Varga
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

9.  The value of contrast dobutamine stress echocardiography on detecting coronary artery disease in overweight and obese patients.

Authors:  Shen-Jiang Hu; Sheng-Xiang Liu; H A Katus; M Luedde
Journal:  Can J Cardiol       Date:  2007-09       Impact factor: 5.223

10.  Quantitative three-dimensional wall motion analysis predicts ischemic region size and location.

Authors:  Susan L Herz; Takuya Hasegawa; Amgad N Makaryus; Katherine M Parker; Shunichi Homma; Jie Wang; Jeffrey W Holmes
Journal:  Ann Biomed Eng       Date:  2010-01-13       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.